Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2016

Open Access 01-12-2016 | Research article

Breast cancer screening attendance in two Swiss regions dominated by opportunistic or organized screening

Authors: Monika Eichholzer, Aline Richard, Sabine Rohrmann, Seraina M. Schmid, Cornelia Leo, Dorothy J. Huang, Uwe Güth

Published in: BMC Health Services Research | Issue 1/2016

Login to get access

Abstract

Background

In Switzerland, the French-speaking region has an organized breast cancer (BC) screening program; in the German-speaking region, only opportunistic screening until recently had been offered. We evaluated factors associated with attendance to breast cancer screening in these two regions.

Methods

We analyzed the data of 50–69 year-old women (n = 2769) from the Swiss Health Survey 2012. Factors of interest included education level, place of residence, nationality, marital status, smoking history, alcohol consumption, physical activity, diet, self-perceived health, history of chronic diseases and mental distress, visits to medical doctors and cervical and colorectal cancer screening. Outcome measures were dichotomized into ≤2 years since most recent mammography versus >2 years or never.

Results

In the German- and French-speaking regions, mammography attendance within the last two years was 34.9 % and 77.8 %, respectively. In the French region, moderate alcohol consumption (adjusted OR 2.01, 95 % CI 1.28–3.15) increased screening attendance. Compared to those with no visit to a physician during the recent year, women in both regions with such visits attended statistically significantly more often BC screening (1–5 times vs. no visit: German (adjusted OR 3.96, 95 % CI 2.58–6.09); French: OR 7.25, 95 % CI 4.04–13.01). Non-attendance to cervical screening had a negative effect in both the German (adjusted OR 0.44, 95 % CI 0.25–0.79) and the French region (adjusted OR 0.57, 95 % CI 0.35–0.91). The same was true for colorectal cancer screening (German (adjusted OR 0.66, 95 % CI 0.52–0.84); French: OR 0.52, 95 % CI 0.33–0.83). No other factor was associated with BC screening and none of the tests of interaction comparing the two regions revealed statistically significant results.

Conclusion

The effect of socio-demographic characteristics, lifestyle, health factors and screening behavior other than mammography on non-attendance to BC screening did not differ between the two regions with mainly opportunistic and organized screening, respectively, and did not explain the large differences in attendance between regions. Other potential explanations such as public promotion of attendance for BC screening, physicians’ recommendations regarding mammography participation or women’s beliefs should be further investigated.
Literature
1.
Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition—summary document. Ann Oncol. 2008;19(4):614–22.PubMedCrossRef
2.
Ouedraogo S, Dabakuyo-Yonli TS, Amiel P, Dancourt V, Dumas A, Arveux P. Breast cancer screening programmes: challenging the coexistence with opportunistic mammography. Patient Educ Couns. 2014;97(3):410–7.PubMedCrossRef
3.
Bulliard JL, Ducros C, Dayer E, Arzel B, Levi F. Variation in performance in low-volume mammography screening programmes: experience from Switzerland. Cancer Epidemiol. 2011;35(3):293–7.PubMedCrossRef
4.
5.
Bryan L, Westmaas L, Alcaraz K, Jemal A. Cigarette smoking and cancer screening underutilization by state: BRFSS 2010. Nicotine Tob Res. 2014;16(9):1183–9.PubMedCrossRef
6.
Martin-Lopez R, Hernandez-Barrera V, De Andres AL, Garrido PC, De Miguel AG, Garcia RJ. Breast and cervical cancer screening in Spain and predictors of adherence. Eur J Cancer Prev. 2010;19(3):239–45.PubMedCrossRef
7.
Lagerlund M, Drake I, Wirfalt E, Sontrop JM, Zackrisson S. Health-related lifestyle factors and mammography screening attendance in a Swedish cohort study. Eur J Cancer Prev. 2015;24(1):44–50.PubMedCrossRef
8.
Xiang X. Serious psychological distress as a barrier to cancer screening among women. Womens Health Issues. 2015;25(1):49–55.PubMedCrossRef
9.
Gonzalez P, Castaneda SF, Mills PJ, Talavera GA, Elder JP, Gallo LC. Determinants of breast, cervical and colorectal cancer screening adherence in Mexican-American women. J Community Health. 2012;37(2):421–33.PubMedPubMedCentralCrossRef
10.
Damiani G, Federico B, Basso D, Ronconi A, Bianchi CB, Anzellotti GM, Nasi G, Sassi F, Ricciardi W. Socioeconomic disparities in the uptake of breast and cervical cancer screening in Italy: a cross sectional study. BMC Public Health. 2012;12:99.PubMedPubMedCentralCrossRef
11.
Martin-Lopez R, Jimenez-Garcia R, Lopez-de-Andres A, Hernandez-Barrera V, Jimenez-Trujillo I, Gil-de-Miguel A, Carrasco-Garrido P. Inequalities in uptake of breast cancer screening in Spain: analysis of a cross-sectional national survey. Public Health. 2013;127(9):822–7.PubMedCrossRef
12.
Duport N. Characteristics of women using organized or opportunistic breast cancer screening in France. Analysis of the 2006 French Health, Health Care and Insurance Survey. Rev Epidemiol Sante Publique. 2012;60(6):421–30.PubMedCrossRef
13.
Andreeva VA, Pokhrel P. Breast cancer screening utilization among Eastern European immigrant women worldwide: a systematic literature review and a focus on psychosocial barriers. Psychooncology. 2013;22(12):2664–75.PubMedCrossRef
14.
Walsh B, Silles M, O’Neill C. The importance of socio-economic variables in cancer screening participation: a comparison between population-based and opportunistic screening in the EU-15. Health Policy. 2011;101(3):269–76.PubMedCrossRef
15.
Palencia L, Espelt A, Rodriguez-Sanz M, Puigpinos R, Pons-Vigues M, Pasarin MI, Spadea T, Kunst AE, Borrell C. Socio-economic inequalities in breast and cervical cancer screening practices in Europe: influence of the type of screening program. Int J Epidemiol. 2010;39(3):757–65.PubMedCrossRef
16.
Eichholzer M, Richard A, Rohrmann S, Schmid S, Guth U. Overweight, obesity, and breast cancer screening: results from the 2012 Swiss Health Survey. Eur J Cancer Prev. 2016;25(2):130–36.
17.
18.
WHO. Mental Health action plan 2013–2010. WHO 2013. 2013.
19.
Bundesamt für Sport BASPO BfGB, Gesundheitsförderung, Schweiz bBfU, Suva, Netzwerk, Schweiz. GuB. Gesundheitswirksame Bewegung. Magglingen: BASPO; 2013.
20.
Carrasco-Garrido P, Hernandez-Barrera V, de Lopez Andres A, Jimenez-Trujillo I, Gallardo Pino C, Jimenez-Garcia R. Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain. Eur J Pub Health. 2014;24(2):264–70.CrossRef
21.
Bonfill X, Marzo M, Pladevall M, Marti J, Emparanza JI. Strategies for increasing women participation in community breast cancer screening. Cochrane Database Syst Rev. 2001;1:CD002943.PubMed
22.
Schumacher MC, Slattery ML, Lanier AP, Ma KN, Edwards S, Ferucci ED, Tom-Orme L. Prevalence and predictors of cancer screening among American Indian and Alaska native people: the EARTH study. Cancer Causes Control. 2008;19(7):725–37.PubMedPubMedCentralCrossRef
23.
Cabeza E, Esteva M, Pujol A, Thomas V, Sanchez-Contador C. Social disparities in breast and cervical cancer preventive practices. Eur J Cancer Prev. 2007;16(4):372–9.PubMedCrossRef
24.
Luengo-Matos S, Polo-Santos M, Saz-Parkinson Z. Mammography use and factors associated with its use after the introduction of breast cancer screening programmes in Spain. Eur J Cancer Prev. 2006;15(3):242–8.PubMedCrossRef
25.
von Euler-Chelpin M, Olsen AH, Njor S, Vejborg I, Schwartz W, Lynge E. Socio-demographic determinants of participation in mammography screening. Int J Cancer. 2008;122(2):418–23.CrossRef
26.
27.
Duport N, Ancelle-Park R. Do socio-demographic factors influence mammography use of French women? Analysis of a French cross-sectional survey. Eur J Cancer Prev. 2006;15(3):219–24.PubMedCrossRef
28.
Sicsic J, Franc C. Obstacles to the uptake of breast, cervical, and colorectal cancer screenings: what remains to be achieved by French national programmes? BMC Health Serv Res. 2014;14:465.PubMedPubMedCentralCrossRef
29.
Bulliard JL, de Landtsheer JP, Levi F. Profile of women not attending in the Swiss Mammography Screening Pilot Programme. Breast. 2004;13(4):284–9.PubMedCrossRef
30.
Chamot E, Perneger TV. Men’s and women’s knowledge and perceptions of breast cancer and mammography screening. Prev Med. 2002;34(3):380–5.PubMedCrossRef
31.
Lynge E, Olsen AH, Fracheboud J, Patnick J. Reporting of performance indicators of mammography screening in Europe. Eur J Cancer Prev. 2003;12(3):213–22.PubMedCrossRef
32.
Wang H, Karesen R, Hervik A, Thoresen SO. Mammography screening in Norway: results from the first screening round in four counties and cost-effectiveness of a modeled nationwide screening. Cancer Causes Control. 2001;12(1):39–45.PubMedCrossRef
33.
Jack RH, Moller H, Robson T, Davies EA. Breast cancer screening uptake among women from different ethnic groups in London: a population-based cohort study. BMJ Open. 2014;4(10), e005586.PubMedPubMedCentralCrossRef
34.
Fontana M, Bischoff A. Uptake of breast cancer screening measures among immigrant and Swiss women in Switzerland. Swiss Med Wkly. 2008;138(49–50):752–8.PubMed
35.
Caleffi M, Ribeiro RA, Bedin Jr AJ, Viegas-Butzke JM, Baldisserotto FD, Skonieski GP, Giacomazzi J, Camey SA, Ashton-Prolla P. Adherence to a breast cancer screening program and its predictors in underserved women in southern Brazil. Cancer Epidemiol Biomarkers Prev. 2010;19(10):2673–9.PubMedCrossRef
36.
Vander Weg MW, Howren MB, Cai X. Use of routine clinical preventive services among daily smokers, non-daily smokers, former smokers, and never-smokers. Nicotine Tob Res. 2012;14(2):123–30.PubMedCrossRef
37.
Feunekes GI, van’t Veer P, van Staveren WA, Kok FJ. Alcohol intake assessment: the sober facts. Am J Epidemiol. 1999;150(1):105–12.PubMedCrossRef
38.
Gorin SS, Jacobson J. Diet and breast cancer surveillance behaviors among Harlem women. Ann N Y Acad Sci. 2001;952:153–60.PubMedCrossRef
39.
Galan I, Rodriguez-Artalejo F, Diez-Ganan L, Tobias A, Zorrilla B, Gandarillas A. Clustering of behavioural risk factors and compliance with clinical preventive recommendations in Spain. Prev Med. 2006;42(5):343–7.PubMedCrossRef
40.
Lopez-de-Andres A, Martin-Lopez R, Hernandez-Barrera V, Carrasco-Garrido P, Gil-de-Miguel A, MM E y P, Jimenez-Garcia R. Predictors of breast and cervical cancer screening in a Spanish metropolitan area. J Women’s Health. 2010;19(9):1675–81.CrossRef
41.
Cullati S, Charvet-Berard AI, Perneger TV. Cancer screening in a middle-aged general population: factors associated with practices and attitudes. BMC Public Health. 2009;9:118.PubMedPubMedCentralCrossRef
42.
Schueler KM, Chu PW, Smith-Bindman R. Factors associated with mammography utilization: a systematic quantitative review of the literature. J Womens Health (Larchmt). 2008;17(9):1477–98.CrossRef
43.
Meystre-Agustoni G, Paccaud F, Jeannin A, Dubois-Arber F. Anxiety in a cohort of Swiss women participating in a mammographic screening programme. J Med Screen. 2001;8(4):213–9.PubMedCrossRef
44.
Howard M, Agarwal G, Lytwyn A. Accuracy of self-reports of Pap and mammography screening compared to medical record: a meta-analysis. Cancer Causes Control. 2009;20(1):1–13.PubMedCrossRef
45.
Achat H, Close G, Taylor R. Who has regular mammograms? Effects of knowledge, beliefs, socioeconomic status, and health-related factors. Prev Med. 2005;41(1):312–20.PubMedCrossRef
46.
Bulliard JL, de Landtsheer JP, Levi F. Participation in Swiss mammography screening programmes: key role of physicians. Praxis. 2005;94(36):1381–7.PubMedCrossRef
47.
Keller B, Stutz EZ, Tibblin M, Ackermann-Liebrich U, Faisst K, Probst-Hensch N. Screening mammographies in Switzerland: what makes female and male physicians prescribe them? Swiss Med Wkly. 2001;131(21–22):311–9.PubMed
Metadata
Title
Breast cancer screening attendance in two Swiss regions dominated by opportunistic or organized screening
Authors
Monika Eichholzer
Aline Richard
Sabine Rohrmann
Seraina M. Schmid
Cornelia Leo
Dorothy J. Huang
Uwe Güth
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2016
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-016-1760-4

Other articles of this Issue 1/2016

BMC Health Services Research 1/2016 Go to the issue

Research article

Effects of China’s New Rural Cooperative Medical Scheme on reducing medical impoverishment in rural Yanbian: An alternative approach

Research article

A value proposition for early physical therapist management of neck pain: a retrospective cohort analysis

Research article

A prospective evaluation of first people’s health promotion program design in the goulburn-murray rivers region

Research article

Recommendations from primary care providers for integrating mental health in a primary care system in rural Nepal

Research article

Evaluating a complex model designed to increase access to high quality primary mental health care for under-served groups: a multi-method study

Research article

Development of a video-based education and process change intervention to improve advance cardiopulmonary resuscitation decision-making